These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 7346733)
1. Effect of growth hormone on human drug metabolism: time course and substrate specificity. Redmond GP; Bell JJ; Nichola PS; Perel JM Pediatr Pharmacol (New York); 1980; 1(1):63-70. PubMed ID: 7346733 [TBL] [Abstract][Full Text] [Related]
2. Effect of human growth hormone on amobarbital metabolism in children. Redmond GP; Bell JJ; Perel JM Clin Pharmacol Ther; 1978 Aug; 24(2):213-8. PubMed ID: 679599 [TBL] [Abstract][Full Text] [Related]
3. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone. Rudman D; Kutner MH; Chawla RK; Goldsmith MA J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201 [TBL] [Abstract][Full Text] [Related]
4. Regulation of theophylline metabolism by growth hormone. Redmond GP Semin Perinatol; 1981 Oct; 5(4):374-7. PubMed ID: 7302613 [No Abstract] [Full Text] [Related]
5. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth? Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229 [TBL] [Abstract][Full Text] [Related]
6. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure. Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone distribution kinetics are markedly reduced in adults with growth hormone deficiency. Catalina PF; Páramo C; Andrade MA; Mallo F Clin Endocrinol (Oxf); 2007 Mar; 66(3):341-7. PubMed ID: 17302866 [TBL] [Abstract][Full Text] [Related]
8. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study. Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559 [TBL] [Abstract][Full Text] [Related]
9. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926 [TBL] [Abstract][Full Text] [Related]
10. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome. Collett-Solberg PF; Pessoa de Queiroz AN; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209 [TBL] [Abstract][Full Text] [Related]
11. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency]. Olsovská V; Siprová H; Beránek M; Soska V Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102 [TBL] [Abstract][Full Text] [Related]
12. Effects of human growth hormone on blood polyamines in hypopituitarism. Bernasconi S; Casti A; Orlandini G; Reali N; Virdis R; Giovannelli G Helv Paediatr Acta; 1980 May; 35(2):141-8. PubMed ID: 7451229 [TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of lactosaminated recombinant human growth hormone in mice. Li YC; Guan CT; Zhao KQ; Chen ZL; Li TL Acta Pharmacol Sin; 2001 May; 22(5):450-4. PubMed ID: 11743895 [TBL] [Abstract][Full Text] [Related]
17. Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone. Finkenstedt G; Höfle G; Pallua A; Sailer U; Gasser RW Wien Klin Wochenschr; 1999 Nov; 111(21):887-90. PubMed ID: 10599151 [TBL] [Abstract][Full Text] [Related]
18. Growth and growth hormone therapy in children with achondroplasia: a two-year experience. Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079 [TBL] [Abstract][Full Text] [Related]
19. Effect of 12 months of recombinant human growth hormone replacement therapy on insulin sensitivity in GH-deficient adults as determined by different methods. Micic D; Cvijovic G; Doknic M; Kendereski A; Popovic V J Postgrad Med; 2002; 48(4):260-5; discussion 265. PubMed ID: 12571379 [TBL] [Abstract][Full Text] [Related]
20. A multi-dose study on the human metabolism of amylobarbitone. Baldeo WC; Gilbert JN; Powell JW Xenobiotica; 1979 Apr; 9(4):205-8. PubMed ID: 483856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]